Accessibility: Skip TopNav
Comparison of the 24-month DDAF lesion growth between Tinlarebant-treated subjects and ProgStar participants
Comparison of the 24-month DDAF lesion growth between Tinlarebant-treated subjects and ProgStar participants
Format
PNG
Quelle:
Belite Bio, Inc
Downloads
Originalgröße
Groß
Mittel
Klein